← k3vl4r
Log inGet started →

CDNA (CareDx) Price Forecast

AI-generated price forecast for CareDx (CDNA) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads CDNA as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 74.13. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

74.13

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

CDNA forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+273.96%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called CDNA's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest CDNA news

From the market-news feed the forecasts are read against.

  • Wall Street Analysts Think CareDx (CDNA) Could Surge 28.09%: Read This Before Placing a Bet · Yahoo · Nov 17
  • Recent Analysts’ Ratings Updates for CareDx (CDNA) · ldr:themarketsdaily.com · Nov 11
  • Piper Sandler Initiates Coverage On CareDx with Overweight Rating, Announces Price Target of $100 · Benzinga · Nov 11
  • Favorable Medicare Coverage Ruling Drives CareDx’s (CDNA) Q3 Performance · Yahoo · Nov 10
  • Should Earnings Upgrade Require Action From CareDx Stock Investors? · Yahoo · Nov 8

🔒

See the full CDNA forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

CDNA forecast — frequently asked

Will CDNA go up?

K3vl4r's calibrated AI forecast currently reads CDNA as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the CDNA price prediction for 2026?

K3vl4r's model projects CDNA toward $274.86 over the next ~4 weeks, a +274.0% move from $73.50. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

REGNPRTAMRNARXRXAMGNGILDNTLAGERNJAZZNBIXOPKNVAXFATEBEAM

Will CDNA reach…?

Will CDNA reach $100.00?Will CDNA reach $200.00?Will CDNA reach $250.00?Will CDNA reach $500.00?

Or see the full CDNA price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare CDNA

CDNA vs REGNCDNA vs PRTACDNA vs MRNACDNA vs RXRXCDNA vs AMGNCDNA vs GILD

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.